QA: Organogenesis Holdings Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001661181_2022_Organogenesis_Holdings_Inc.pdf

Logs

Graph

Absolute values for 0001661181, Organogenesis Holdings Inc

  xvar xval
0 AssetsCurrent 226,979,000
1 IntangibleAssetsNetIncludingGoodwill 54,445,000
2 PropertyPlantAndEquipmentNet 79,160,000
3 remainder_Assets 82,675,000
4 LiabilitiesCurrent 82,005,000
5 LiabilitiesNoncurrent 48,450,000
6 remainder_Liabilities 70,769,000
7 CostOfGoodsAndServicesSold 120,045,410
8 SellingGeneralAndAdministrativeExpense 264,337,554
9 ResearchAndDevelopmentExpense 55,888,433
10 remainder_Expenses -1,444,855
11 remainder_Revenues 641,705,917
12 remainder_NetIncome -9,106,945
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 443,259,000
1 Liabilities 201,224,000
2 Expenses 438,826,542
3 Revenues 641,705,917
4 StockholdersEquity 242,035,000
5 NetIncome 193,772,430
6 ComprehensiveNetIncome 193,772,430
7 BaseVar 867,061,202
8 EconomicCapitalRatiobeforeLimitedLiability 2.24
9 EconomicCapitalRatio 3.18

Edgar->Model Mapping

Feature Distribution

Change over Time